ISOLAGEN, INC. Registration Rights AgreementRegistration Rights Agreement • November 4th, 2004 • Isolagen Inc • Pharmaceutical preparations • New York
Isolagen, Inc., a Delaware corporation (the "Company"), proposes to issue and sell to the Purchasers (as defined herein) upon the terms set forth in the Purchase Agreement (as defined herein) its 3.5% Convertible Subordinated Notes due 2024 (the "Securities"). As an inducement to the Purchasers to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Purchasers thereunder, the Company agrees with the Purchasers for the benefit of holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows:
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 4th, 2004 • Isolagen Inc • Pharmaceutical preparations • Delaware
SECURITIES PURCHASE AGREEMENT, effective as of November 2, 2004 (this "Agreement"), by and among those individuals enumerated on Exhibit A hereto (the "Sellers") and Isolagen, Inc., a Delaware corporation (the "Purchaser").
